Cardiac angiosarcoma: A diagnostic and therapeutic challenge

Area of Science:

• Oncology
• Cardiovascular Surgery
• Radiotherapy

Background:

• Cardiac angiosarcomas are rare, aggressive soft tissue sarcomas with no standard treatment.
• Surgical resection offers the best outcomes for localized disease but is often technically challenging or infeasible.
• Upfront chemoradiotherapy is an alternative to shrink tumors for subsequent surgical resection.

Observation:

• A case of primary cardiac angiosarcoma in a young patient with locally advanced disease is presented.
• The patient received upfront chemoradiotherapy with paclitaxel.
• A complete metabolic and pathological response was observed post-treatment.

Findings:

• Upfront chemoradiotherapy with paclitaxel led to a dramatic tumor response.
• The patient subsequently underwent successful surgical resection.
• This multimodal approach resulted in a complete pathological response.

Implications:

• This case highlights upfront chemoradiotherapy followed by surgery as a viable treatment strategy for cardiac angiosarcoma.
• This aggressive, combined treatment approach may improve outcomes for patients with this rare and challenging condition.
• Further research into neoadjuvant therapies for cardiac angiosarcoma is warranted.